Statistics for Regulatory and cost barriers are likely to limit biosimilar development and expected savings in the near future.
Total visits
views | |
---|---|
Regulatory and cost barriers are likely to limit biosimilar development and expected savings in the near future. | 445 |
Total visits per month
views | |
---|---|
March 2024 | 0 |
April 2024 | 1 |
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
File Visits
views | |
---|---|
Grabowski_Guha_Salgado_Health Affairs_ June 2014.pdf | 636 |
Top country views
views | |
---|---|
United Kingdom | 293 |
United States | 32 |
Germany | 28 |
China | 6 |
Denmark | 3 |
India | 3 |
Singapore | 3 |
France | 2 |
South Korea | 2 |
Canada | 1 |
Switzerland | 1 |
Egypt | 1 |
Italy | 1 |
Top city views
views | |
---|---|
Alexandria | 201 |
Kiez | 16 |
Ballerup | 3 |
Changi | 3 |
Guntur | 3 |
New York | 3 |
Washington | 3 |
Durham | 2 |
Philadelphia | 2 |
Seattle | 2 |
Seoul | 2 |
Woodbridge | 2 |
Alpharetta | 1 |
Arlington | 1 |
Bedford | 1 |
Boardman | 1 |
Boston | 1 |
Bronx | 1 |
Brooklyn | 1 |
Dalian | 1 |
Maggia | 1 |
Mount Laurel | 1 |
Mountain View | 1 |
Overland Park | 1 |
Sainte-thérèse | 1 |
Staatsburg | 1 |
Suzhou | 1 |
Union | 1 |
Wilmington | 1 |
Yulee | 1 |